Sort
10,766 grants matching “checkpoint inhibitor”
SBIR FY25 Concept Award, Development of an Immunotherapy for Ewing Sarcoma Using a Novel Murine Model
$355,000Merlin Biotech Inc · N43 · FY2025 · CA
Reprogramming myeloid cells to inhibit cancer development
$354,961Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Antigen-specific T cells in immunotherapy-associated acute kidney injury
$354,960Naoka Murakami · Brigham And Women'S Hospital · R01 · FY2024 · DK
Mre11/Rad50 Structural Biology for DNA Damage Responses
$354,869John A Tainer · Scripps Research Institute, The · R01 · FY2008 · CA
Mre11/Rad50 Structural Biology for DNA Damage Responses
$354,869John A Tainer · Scripps Research Institute, The · R01 · FY2009 · CA
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$354,835Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
T Cell Immunity in Giant Cell Arteritis
$354,759Cornelia M Weyand · Mayo Clinic Rochester · R01 · FY2021 · HL
Project 3: Hedgehog Inhibition to Enhance Response to ICI Therapy
$354,574Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Development of a targeted delivery platform for checkpoint inhibitors
$354,563Kun Cheng · University Of Missouri Kansas City · R01 · FY2021 · CA
PRE-B CELL RECEPTOR SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA
$354,563Markus Mãschen · University Of California, San Francisco · R01 · FY2014 · CA
Development of a targeted delivery platform for checkpoint inhibitors
$354,563Kun Cheng · University Of Missouri Kansas City · R01 · FY2020 · CA
Development of a targeted delivery platform for checkpoint inhibitors
$354,563Kun Cheng · University Of Missouri Kansas City · R01 · FY2018 · CA
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers
$354,563Wei R. Chen · University Of Oklahoma · R01 · FY2021 · CA
Aging and DNA damage: Mechanisms for extending health span
$354,473Jan Hoeijmakers · Albert Einstein College Of Medicine, Inc · P01 · FY2016 · AG
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC
$354,464Lingtao Jin · University Of Texas Hlth Science Center · R01 · FY2023 · CA
The Role of Stromal Autophagy in Cutaneous Melanoma
$354,445Hilary A Coller · University Of California Los Angeles · R01 · FY2019 · CA
Genome-wide mapping and characterization of exitrons in human cancer
$354,433Rendong Yang · Northwestern University At Chicago · R01 · FY2025 · CA
Synthesis and evaluation of BTN3A1 ligands for cancer immunotherapy
$354,363Andrew J Wiemer · University Of Connecticut Storrs · R01 · FY2023 · CA
The role of HIF2alpha in colon carcinogenesis
$354,320Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Development of cambinol analogues as antilymphoma agents
$354,244Antonio Bedalov · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Development of cambinol analogues as antilymphoma agents
$354,244Antonio Bedalov · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Regulation of PD-L1/PD-1 immune checkpoints by cis-interactions
$354,197Enfu Hui · University Of California, San Diego · R37 · FY2023 · CA
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
$354,168Sameek Roychowdhury · Ohio State University · UH2 · FY2017 · CA
Dual-pronged nano-drug delivery using plant virus-like particles
$354,119Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA
Defining the determinants of response and resistance to therapy for Richter's Syndrome
$354,075Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2024 · CA